Most Clicked StoriesMore >


Report: Biosimilar market to expand rapidly

BIO SmartBrief | Jul 02, 2015

The worldwide market for biosimilars could reach $55 billion by 2020 and biologics could replace as much as 70% of the chemical drug market in the next 20 years, according to a report from GBI Research. GBI pointed to 642 biosimilar trials underway, with more than half focused on oncology and immunotherapy treatments. BioSpectrum Asia (07/01)


Baxter announces Baxalta spinoff

BIO SmartBrief | Jul 02, 2015

Celgene, Juno sign $1B collaboration deal

BIO SmartBrief | Jun 30, 2015

Bristol-Myers Squibb ceases antiviral discovery program

BIO SmartBrief | Jun 29, 2015

Judge rules against biotech crop ban in Maui County

BIO SmartBrief | Jul 01, 2015

Novartis acquires biotech firm Spinifex

BIO SmartBrief | Jun 30, 2015

Drugs from Immunovaccine, Incyte to be combined in cancer trial

BIO SmartBrief | Jun 29, 2015

Juno's lymphoma drug application accepted by FDA

BIO SmartBrief | Jun 30, 2015

Seres pulls in $134M from IPO

BIO SmartBrief | Jun 29, 2015

AstraZeneca partners with Eolas on smoking cessation therapy in $145M deal

BIO SmartBrief | Jul 01, 2015


Find BIO SmartBrief Issues by Date:



BIO News More >


Secure document sharing services optimized for life science organizations

BIO SmartBrief | Jul 02, 2015

Savings on environmental waste disposal services

BIO SmartBrief | Jul 02, 2015

Industrial biotechnology with a French twist!

BIO SmartBrief | Jul 01, 2015

Faster & better connections with quality R&D vendors

BIO SmartBrief | Jul 01, 2015

Find the experienced biotech talent that your company needs

BIO SmartBrief | Jun 30, 2015




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more